Axsome Therapeutics, Inc. (AXSM)
Nasdaq: AXSM · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2013
Who runs Axsome Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Tabuteau Herriot
Chief Executive Officer. First filing Nov 2015, latest Aug 7, 2026, 9 filings in all.
Officers reporting now
5
of 9 people with a filing in the last fifteen months
Directors reporting now
4
13 people on the record since 2015
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Jacobson Mark L. | Chief Operating Officer | Mar 2020 | Sep 3, 2026 | 4 · $8.9M |
| Tabuteau Herriot | Chief Executive Officer | Nov 2015 | Aug 7, 2026 | 17 · $103M |
| Pizzie Nick | Chief Financial Officer | May 2018 | Jun 9, 2026 | 2 · $10.2M |
| Maizel Ari | Chief Commercial Officer | Oct 2024 | Apr 23, 2026 | 2 · $2.8M |
| Murdock Hunter R. | General Counsel | Jun 2022 | Apr 23, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Jeffs Roger | director | Nov 2015 | Jun 11, 2026 | 2 · $100,000 |
| Coleman Mark | director | Nov 2015 | Jun 10, 2026 | 5 · $8.2M |
| Mahony Susan | director | Oct 2023 | Jun 10, 2026 | 2 · $100,000 |
| Saad Mark E | director | Nov 2015 | Jun 10, 2026 | 2 · $6.2M |
Earlier names on the record4, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.